Neurology Flashcards
Indication for dopamine transporter scan
Differentiate Parkinson disease from essential tremor or drug-induced parkinsonism
MKSAP 20
Common causes of subacute combined degeneration
Vitamin B12 and copper deficiencies
MKSAP 20
Target SBP in intracerebral hemorrhage
130 to 150 mm Hg
MKSAP 20
Posthypoxic positive and negative myoclonus with action and gait
Lance-Adams syndrome
MKSAP 20
Refractory daily headaches with triptan, ergot alkaloid, opioid, or combination analgesic use ≥10 days/month
Medication overuse headache
MKSAP 20
Acute-onset headache, proptosis, periorbital edema, ophthalmoplegia
Cavernous sinus thrombosis
MKSAP 20
Procedure confirming normal-pressure hydrocephalus diagnosis
Lumbar puncture and large-volume CSF removal
MKSAP 20
Outpatient test for embolic stroke of undetermined source
Prolonged cardiac monitoring
MKSAP 20
Method for diagnosing NCSE
Continuous EEG monitoring
MKSAP 20
Bell palsy treatment
Prednisone
MKSAP 20
Adjuvant therapy for catamenial seizures
Progestin-containing oral contraceptives or acetazolamide
MKSAP 20
Most common/disabling symptom of mild TBI
Headache
MKSAP 20
Acute subdural hematoma surgery indications
Hematoma >10 mm, GCS score <9, pupillary asymmetry/fixation
MKSAP 20
Respiratory function monitoring in GBS
Serial FVC and negative inspiratory force
MKSAP 20
Management of asymptomatic carotid stenosis
Statin therapy
MKSAP 20
Nondrug management for ICU delirium
Early mobilization, family engagement, catheter removal, visual/hearing aids, calm redirection
MKSAP 20
Threshold migraine frequency for consideration of preventive medication
4 days/month
MKSAP 20
ALS drug treatment
Riluzole, edaravone, sodium phenylbutyrate–taurursodiol
MKSAP 20
Goal BP after stroke thrombolysis
<180/105 mm Hg
MKSAP 20
Emergent treatment of brain herniation
Elevation of the head of the bed, hyperventilation, mannitol, glucocorticoids
MKSAP 20
Carpal tunnel syndrome surgery indications
Weakness, thenar atrophy, refractory pain, active denervation on EMG/nerve conduction studies
MKSAP 20
Indication for stenting in intracranial atherosclerosis for secondary stroke prevention
None
MKSAP 20
Primary progressive MS treatment
Ocrelizumab
MKSAP 20
Factors that can cause seizures in patients without epilepsy
Provoking factors
MKSAP 20
Essential tremor drug treatment
Propranolol, primidone, or topiramate
MKSAP 20
Seizures not treated with ASDs
Alcohol- or benzodiazepine-withdrawal seizures
MKSAP 20
ASDs refer to antiepileptic drugs.
Initial Parkinson disease therapy for motor symptoms
Levodopa
MKSAP 20
Levodopa is often combined with carbidopa to enhance its effectiveness.
Chorea, ataxia, psychiatric disease, parkinsonism, dementia
Huntington disease
MKSAP 20
Huntington disease is a genetic disorder caused by a mutation in the HTT gene.
MRI findings in posterior reversible encephalopathy syndrome
Parietal and occipital white matter edema, occasionally intracranial hemorrhage
MKSAP 20
This syndrome is often associated with conditions like hypertension and eclampsia.
Leading mechanisms of TBI in older persons
Falls, motor vehicle collisions, accidental blows to the head
MKSAP 20
TBI stands for traumatic brain injury.
Initial test to determine candidacy for epilepsy surgery
Video EEG monitoring
MKSAP 20
This test helps to localize the seizure focus.
Rapidly progressive dementia, myoclonus, gait problems, visual compromise
Creutzfeldt-Jakob disease
MKSAP 20
This disease is a type of prion disease.
First-line treatments for relapsing-remitting MS
Ocrelizumab, ofatumumab, natalizumab, alemtuzumab
MKSAP 20
MS stands for multiple sclerosis.
Upper and lower motor neuron signs without sensory involvement
ALS
MKSAP 20
ALS stands for amyotrophic lateral sclerosis.
Test for suspected subarachnoid hemorrhage and normal head CT scan
Lumbar puncture
MKSAP 20
This test can detect xanthochromia in the cerebrospinal fluid.
Preventive medication for tension-type headache
Amitriptyline
MKSAP 20
Amitriptyline is a tricyclic antidepressant.
Test for PNES
Video EEG monitoring
MKSAP 20
PNES stands for psychogenic non-epileptic seizures.
ASD that should be used cautiously in older patients
Valproate
MKSAP 20
Valproate can have significant side effects in older populations.
Emergent pharmacologic treatment of brain tumor–related herniation
Dexamethasone
MKSAP 20
Dexamethasone is a corticosteroid used to reduce inflammation.
Medication for cognitive symptoms of dementia with Lewy bodies
Acetylcholinesterase inhibitors (off-label use)
MKSAP 20
Common medications include donepezil and rivastigmine.
Typical duration of mild TBI symptoms
Within 7-10 days
MKSAP 20
Mild TBI is often referred to as a concussion.
Migraine aura subtypes
Typical, brainstem, hemiplegic, retinal
MKSAP 20
Each subtype has distinct clinical features.
Red flags for secondary headache
New, different, or progressive headache; abrupt, positional, or exertional onset
MKSAP 20
These symptoms may indicate a serious underlying condition.
Monthly threshold for simple analgesic use for diagnosing medication overuse headache
≥15 days/month
MKSAP 20
This condition is also known as rebound headache.
Unprovoked seizure treatment indications
Two unprovoked seizures or one unprovoked seizure with EEG or MRI abnormalities
MKSAP 20
This is a key criterion for starting antiepileptic therapy.
Treatment for migraine unresponsive to NSAIDs over three episodes
Triptans
MKSAP 20
Triptans are a class of medications specifically designed for migraine relief.
Diagnostic test for periodic limb movements of sleep
Polysomnography
MKSAP 20
This test monitors brain waves, oxygen levels, heart rate, and breathing.
Subacute transient shoulder pain followed by progressive weakness
Idiopathic brachial plexitis
MKSAP 20
This condition is also known as Parsonage-Turner syndrome.
Treatment of statin-induced immune-mediated necrotizing myopathy
Immunosuppression and discontinuation of statin
MKSAP 20
This condition can lead to muscle weakness and pain.
Mnemonic for migraine characteristics
POUND (Pulsatile quality, One-day duration, Unilateral location, Nausea/vomiting, Disabling intensity)
MKSAP 20
This mnemonic helps in identifying migraine features.
Evaluation for restless legs syndrome
Ferritin, iron studies
MKSAP 20
Ferritin and iron studies help assess for iron deficiency, which can be a contributing factor in restless legs syndrome.
Earliest timing for withdrawing blood pressure therapy in intracerebral hemorrhage (ICH)
After 48 hours
MKSAP 20
This timing is critical to manage blood pressure and reduce the risk of rebleeding.
Definition of drug-resistant epilepsy
Continued seizures in patients taking ≥2 ASDs
MKSAP 20
ASDs refer to antiepileptic drugs.
First-line drug treatment for idiopathic intracranial hypertension
Acetazolamide
MKSAP 20
Topiramate may also be used for its weight-loss benefits.
Sleep disorder characterized by triple-flexion leg kicks
Periodic limb movements of sleep
MKSAP 20
This condition often disrupts sleep and can lead to daytime sleepiness.
Brain pathology findings in athletes retired from contact sports
Chronic traumatic encephalopathy
MKSAP 20
This condition is associated with repetitive head trauma.
Symptoms of POEMS syndrome
Peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes
MKSAP 20
POEMS syndrome is a rare paraneoplastic syndrome.
Characteristics of idiopathic transverse myelitis
Complete myelitis, no CSF oligoclonal bands or IgG index, no brain MRI lesions
MKSAP 20
This condition often presents with acute neurological deficits.
Imaging modalities for reversible cerebral vasoconstriction syndrome
Brain MRI, cranial and cervical MRA or CTA
MKSAP 20
These imaging studies help visualize vascular changes in the brain.
Symptoms of subacute combined degeneration from severe vitamin B12 deficiency
Paresthesias, reduced vibration/position sense, ataxia; spasticity/paraplegia if severe
MKSAP 20
Vitamin B12 is crucial for neurological function.
Contraindications for acetylcholinesterase inhibitors
Bradycardia, hypotension
MKSAP 20
These conditions can be exacerbated by the use of acetylcholinesterase inhibitors.
Movement disorder related to dopamine-blocking agents
Tardive dyskinesia
MKSAP 20
This condition is characterized by involuntary movements and can be a side effect of long-term antipsychotic use.
Description of occipital neuralgia
Acute, unilateral, lancinating posterior headache with movement of cervical spine
MKSAP 20
Occipital neuralgia is often due to irritation or injury of the occipital nerves.
Indications for surgery in asymptomatic saccular aneurysms
> 12 mm (anterior circulation); >7 mm (posterior circulation)
MKSAP 20
These sizes are considered thresholds for surgical intervention to prevent rupture.
Treatment for primary cough headache and primary stabbing headache
Indomethacin
MKSAP 20
Indomethacin is a nonsteroidal anti-inflammatory drug effective for these headache types.
Clinical syndrome associated with chronic traumatic encephalopathy
Traumatic encephalopathy syndrome
MKSAP 20
This syndrome includes cognitive, mood, and behavioral changes.
Active secondary progressive multiple sclerosis treatment
Disease-modifying therapy, e.g., ocrelizumab, ofatumumab, natalizumab, alemtuzumab
MKSAP 20
These therapies aim to slow disease progression.
Preferred study for evaluating internal carotid artery stenosis
Duplex ultrasonography
MKSAP 20
This non-invasive test assesses blood flow and vessel narrowing.
Neurologic complication of natalizumab therapy
Progressive multifocal leukoencephalopathy
MKSAP 20
This serious condition is caused by the JC virus in immunocompromised patients.
Initial treatment of idiopathic transverse myelitis
IV methylprednisolone
MKSAP 20
High-dose corticosteroids are used to reduce inflammation.
Test for Miller-Fisher variant of Guillain-Barré syndrome
Antibodies to GQ1b ganglioside protein
MKSAP 20
This test helps confirm the diagnosis of the variant.
Test in biopsy-inaccessible suspected primary CNS lymphoma
Vitreous or cerebrospinal fluid sampling
MKSAP 20
These samples can provide diagnostic information when a biopsy is not possible.
Diagnosis suggested by seizures, mesial temporal sclerosis, and hippocampal atrophy on MRI
Temporal lobe epilepsy
MKSAP 20
This type of epilepsy is often associated with structural brain changes.
Screening test for backward falls in Parkinson disease
Pull test
MKSAP 20
This test assesses postural stability and risk of falls.
Diagnosis indicated by language loss before cognitive dysfunction
Primary progressive aphasia
MKSAP 20
This condition primarily affects language abilities while sparing other cognitive functions initially.
Typical temporal lobe epilepsy symptoms
Aura, loss of awareness, staring, behavioral arrest, amnesia
MKSAP 20
Infrequent, short durations of altered awareness manifested as staring episodes
Focal unaware seizures
MKSAP 20
Medications that may exacerbate myasthenia gravis
Aminoglycosides, fluoroquinolones, magnesium, β-blockers, hydroxychloroquine
MKSAP 20
Shaking, tunnel vision, <1 min loss of consciousness, immediate recovery
Convulsive syncope
MKSAP 20
MS fatigue drug treatment
Modafinil, armodafinil (off-label use), amantadine (off-label use), methylphenidate (off-label use)
MKSAP 20
Autoimmune cause of chorea, psychosis, seizures, autonomic instability
Anti-NMDAR antibody encephalitis
MKSAP 20
Antiplatelets for secondary prevention of noncardioembolic stroke
Aspirin, clopidogrel, or aspirin-dipyridamole
MKSAP 20
Sequelae of mild TBI in military personnel
PTSD, depression, anxiety, insomnia, cognitive and balance disorders
MKSAP 20
Management of unceasing CSE after IV benzodiazepine and ASD
Intubation; anesthetically induced coma for 24-48 h (propofol, midazolam, or pentobarbital)
MKSAP 20
Clue for epilepsy in a patient with a new-onset seizure
History of staring events or myoclonus
MKSAP 20
ASD associated with Stevens-Johnson syndrome, toxic epidermal necrolysis, DIHS (DRESS)
Lamotrigine
MKSAP 20
Trigeminal neuralgia treatment
Carbamazepine or oxcarbazepine
MKSAP 20
Most common form of genetic generalized epilepsy in adults
Juvenile myoclonic epilepsy
MKSAP 20
CSF findings that predict Alzheimer disease
Decreased amyloid-β peptide, increased total and phosphorylated tau
MKSAP 20
Blood tests for slowly progressive dementia
CMP, CBC, vitamin B12, 25-hyhdroxyvitamin D, TSH; consider treponemal antibody test
MKSAP 20
GBS treatment
Plasmapheresis or IVIG
MKSAP 20
Woman of childbearing age with obesity, headaches, visual symptoms, pulsatile tinnitus
Idiopathic intracranial hypertension (pseudotumor cerebri)
MKSAP 20
Confirmatory test for nonconvulsive status epilepticus
Continuous video EEG monitoring
MKSAP 20
Initial Parkinson disease therapy for patients aged <60 years with high dyskinesia risk
Pramipexole, ropinirole, rotigotine
MKSAP 20
Head injury, lucid interval, rapid neurologic compromise
Epidural hematoma
MKSAP 20
Flaccid paralysis with preserved vibration and position sense after prolonged aortic surgery
Anterior spinal artery infarct
MKSAP 20
Imaging modality of choice for TBI
Noncontrast head CT
MKSAP 20
MRI findings of normal-pressure hydrocephalus
Enlarged sylvian fissure, compacted subarachnoid spaces, ventriculomegaly, no cortical atrophy
MKSAP 20
Cluster headache prophylaxis options
Verapamil, galcanezumab
MKSAP 20
Treatment of ischemic stroke–related symptomatic cerebral edema
Decompressive hemicraniectomy
MKSAP 20
Required monitoring with fingolimod therapy
Ophthalmologic (macular edema) and skin (basal cell carcinoma) examinations
MKSAP 20
Threshold stenosis for carotid endarterectomy for secondary stroke prevention
70%; 50-69% with high-risk features
MKSAP 20
Safe options for headache treatment in pregnancy
Acetaminophen, low-dose aspirin, diphenhydramide, metoclopramide
MKSAP 20
Initial treatment of ocular and mild generalized myasthenia
Pyridostigmine
MKSAP 20
Evaluation of first unprovoked seizure
MRI and EEG
MKSAP 20
MS medication for impaired mobility
Dalfampridine
MKSAP 20
Objective cognitive decline without significant functional decline
Mild cognitive impairment
MKSAP 20
Short-term acute therapy for cardioembolic stroke before anticoagulation
Aspirin
MKSAP 20
Diabetes-related acute truncal dermatomal pain and paresthesia
Diabetic mononeuropathy
MKSAP 20
Cognitive impairment that interferes with ADLs
Dementia
MKSAP 20
Mild to moderate Alzheimer disease drug treatment
Acetylcholinesterase inhibitors donepezil, rivastigmine, galantamine
MKSAP 20
Diagnosis suggested by dementia, apathy, disinhibition, changes in eating behaviors, hyperorality, compulsiveness
Behavioral-variant frontotemporal dementia
MKSAP 20
Tension-type headache treatments
Acetaminophen, aspirin, NSAIDs, caffeine-containing compounds
MKSAP 20
Antibody test in myasthenia gravis with weakness of cervical extension
Anti–muscle-specific tyrosine kinase (MuSK)
MKSAP 20
Slow, nonrandom, repetitive, directional twisting and posturing movements
Dystonia
MKSAP 20
Preferred imaging for subacute/chronic headaches with progressive features
Brain MRI
MKSAP 20
Treatment for postdural puncture headache
Bed rest, caffeine; epidural blood patch if refractory or severe
MKSAP 20
Most common cause of thunderclap headache
Subarachnoid hemorrhage
MKSAP 20
Diagnostic evaluation following central or branch retinal artery occlusion
Urgent evaluation for carotid artery stenosis and cardioembolic disease
MKSAP 20
Action and rest tremor, dystonia, a null point
Dystonic tremor
MKSAP 20
Preferred ASD in persons with potential for pregnancy
Levetiracetam, lamotrigine, or oxcarbazepine
MKSAP 20
Cognitive impairment and personality changes after repetitive head trauma
Traumatic encephalopathy syndrome
MKSAP 20
Acute neck pain, eye pain, partial Horner syndrome, ipsilateral cerebral ischemia
Carotid artery dissection
MKSAP 20
CSE therapy for a fosphenytoin-intolerant patient
IV benzodiazepine, then IV levetiracetam or valproate
MKSAP 20
Typical duration of a generalized tonic-clonic seizure
1-3 minutes
MKSAP 20
What condition is characterized by parkinsonism, cerebellar ataxia, dysautonomia, and falls?
Multiple system atrophy
MKSAP 20
What is the treatment for metastatic spinal cord compression?
High-dose glucocorticoids, decompressive surgery and/or radiation therapy
MKSAP 20
What effect do first-generation neuroleptics have in dementia with Lewy bodies?
Worsening of symptoms resembling neuroleptic malignant syndrome
MKSAP 20
What are the best treatments for epilepsy in older patients?
Gabapentin, lamotrigine, levetiracetam
MKSAP 20
What adverse events are associated with dopamine agonists?
Psychosis, impulse control disorder, sleep attacks, confusion
MKSAP 20
What are the indications for meningioma resection?
Neurologic deficits, drug-resistant seizures, severe headaches, peritumoral edema
MKSAP 20
What is the standard treatment for MS relapse?
High-dose glucocorticoids
MKSAP 20
What symptoms are associated with McArdle disease and carnitine palmitoyltransferase II deficiency?
Exercise-induced weakness, cramping, myoglobinuria
MKSAP 20
What is involved in the expedited evaluation for TIA?
ICA imaging and monitoring for atrial fibrillation
MKSAP 20
Which ASDs have mood-stabilizing effects?
Lamotrigine, valproate
MKSAP 20
What is the black-box warning of antipsychotics in patients with dementia?
Increased morbidity and mortality
MKSAP 20
What condition is indicated by new-onset status epilepticus and subacute progressive confusion?
Autoimmune limbic encephalitis
MKSAP 20
What genetic test is used for familial amyloidosis?
Transthyretin (TTR) genetic testing
MKSAP 20
What test is recommended for suspected spinal cord compression?
Emergent MRI
MKSAP 20
Which ASD is associated with anovulation and PCOS?
Valproate
MKSAP 20
What is the definition of a thunderclap headache?
Abrupt-onset, severe headache reaching maximum intensity within 1 minute
MKSAP 20
What are potential physical exam findings in subarachnoid hemorrhage?
Confusion, somnolence, nuchal rigidity, unilateral pupillary dilation, subhyaloid hemorrhages on funduscopy
MKSAP 20
What is the drug treatment for subarachnoid hemorrhage?
Nimodipine
MKSAP 20
What is the treatment for vascular dementia?
Cerebrovascular risk factor modification, acetylcholinesterase inhibitors and/or NMDA antagonists
MKSAP 20
What are the drug therapies for Tourette syndrome?
Aripiprazole, clonidine, guanfacine, topiramate, levetiracetam, tetrabenazine
MKSAP 20
What are the signs of basilar skull fracture?
Periorbital or mastoid bruising, hemotympanum
MKSAP 20
What is the initial treatment of CSE?
IV benzodiazepine or IM midazolam, then IV fosphenytoin
MKSAP 20
What is the treatment for VTE in CNS malignancy?
Therapeutic low-molecular-weight heparin
MKSAP 20